✦ LIBER ✦

A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with relapsed or refractory non-small cell lung cancer

✍ Scribed by Sherman, Carol A.; Herndon, James E.; Watson, Dorothy M.; Green, Mark R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II trial of 6-Hydroxymethylacylf

✍ Jonathan E. Dowell; David H. Johnson; John S. Rogers; Yu Shyr; Nancy McCullough; 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 44 KB

Phase II trial of karenitecin in patient

✍ Miller, Antonius A.; Herndon, James E.; Gu, Lin; Green, Mark R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Phase II Trial of Gemcitabine/Irinotecan

✍ Wolfgang Schuette; Sylke Nagel; Stefan Juergens; Ines Bork; Bettina Wollschlaege 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 508 KB

Phase II trial of amrubicin and carbopla

✍ Hirose, Takashi; Nakashima, Masanao; Shirai, Takao; Kusumoto, Sojiro; Sugiyama, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 227 KB

A phase II study of sunitinib in patient

✍ Han, Ji-Youn; Kim, Hyae Young; Lim, Kun Young; Han, Jong Hee; Lee, You Jin; Kwak 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Prolonged administration of oral etoposi

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 173 KB